Press Releases

Addiction-recovery solution ASCENT hires first wave of virtual peer recovery team and announces first customers

CLEVELAND, Ohio – January 29, 2016 – ASCENT, an addiction-recovery solution that combines 24/7/365 virtual support from experienced peer recovery coaches with an outcomes documented mobile app has completed their coaching hiring process and have announced their first customers. Read More…

The Foundation for Alcoholism Research Funds Breakthrough Research

August 4, 2014 – About two years ago, baclofen appeared on FAR’s horizon and, after considerable reading and inquiring, the Board of Directors determined that a baclofen study was the area for the next grant. Since then, FAR has been working to raise the necessary funds for this study. Read more…

Researchers to study effects of the medication baclofen on addiction

Dr. Teresa Franklin observing brain scans.

Dr. Teresa Franklin observing brain scans.

Middlebury, VT – July 2, 2014 – The Foundation for Alcoholism Research, (FAR), announces the award of a pilot program grant Baclofen for Alcohol Dependence (BFAD): A neuroimaging study to research the effects of a potentially ground-breaking anti-craving medication called baclofen. The grant, issued to the Perelman School of Medicine at the University of Pennsylvania will perform early steps to help establish the usefulness of baclofen to reduce craving for alcohol.

New York Times Article About Low Use of Effective Medicines

I encourage reading the article just published today in the NYT about the low levels of doctors prescribing current medicines that have been shown to be effective for some. It is not only a struggle to change perceptions to raise funds into research, it is also a struggle to change perceptions and get those medicines which are developed accepted by society. Articles like this help change perceptions and are a great benefit to FAR’s mission. Read More…

Pioneer in Addiction Treatment Supports Proposed Research

Sheila-Blume-MD-800x647-resizedThe Foundation for Alcoholism Research (FAR) announces that Sheila Blume, MD endorses the FAR campaign to fund a study on the effects of the medication Baclofen on alcohol dependence. The National Institutes of Health has given the University of Pennsylvania a million dollar+ grant to study Baclofen’s impact on nicotine addiction. The cost to extend this research to study Baclofen’s impact on alcohol dependence is $60,000. FAR has taken on the challenge to raise the $60,000 to fund the alcohol addiction portion to this important research. Read More…

 The Foundation for Alcoholism Funds Naltrexone Research

FAR’s second grant went toward naltrexone research into patients genetically screened as candidates for this medication use (pill form). Read more…

Close
loading...